DR. JOCHEN REISER, MD ,PHD
Osteopathic Medicine at 10 Ave, Miami, FL
License number
Florida 224081
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Florida ME103154
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Florida 224081
Category
Osteopathic Medicine
Type
Nephrology
License number
Florida ME103154
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
1580 NW 10Th Ave, Miami, FL 33136
Phone
(305) 243-2349
(305) 243-3506 (Fax)
(305) 243-4606
(305) 243-3506 (Fax)
(305) 243-4606
Personal information
See more information about JOCHEN REISER at radaris.comName
Address
Phone
5364 Sunset Dr, Miami, FL 33143
7500 53Rd St, Miami, FL 33143
7500 SW 53Rd Ave, Miami, FL 33143
Organization information
See more information about JOCHEN REISER at bizstanding.comJochen Reiser MD,PHD
1611 NW 12 Ave, Miami, FL 33136
Industry:
Internist
Phone:
(305) 585-1111 (Phone)
Jochen A. Reiser
Professional information
See more information about JOCHEN REISER at trustoria.com
Jochen Reiser, Miami FL
Jochen Reiser, Miami FL
Specialties:
Internist
Address:
1500 Nw 12Th Ave, Miami, FL 33136
1580 Nw 10Th Ave, Miami, FL 33136
1580 Nw 10Th Ave, Miami, FL 33136
Education:
Doctor of Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*
Dr. Jochen Reiser - MD (Doctor of Medicine)
Dr. Jochen Reiser - MD (Doctor of Medicine)
Hospitals:
University Of Miami-Nephrology
1475 NW 12Th Ave, Miami 33136
Kendall Regional Medical Center
11750 Bird Rd, Miami 33175
Sylvester Comprehensive Cancer Center/UMHC
1475 West 12Th Ave, Miami 33136
University of Miami Hospital
1400 West 12Th Ave, Miami 33136
University Of Miami-Nephrology
1475 NW 12Th Ave, Miami 33136
Kendall Regional Medical Center
11750 Bird Rd, Miami 33175
Sylvester Comprehensive Cancer Center/UMHC
1475 West 12Th Ave, Miami 33136
University of Miami Hospital
1400 West 12Th Ave, Miami 33136
1475 NW 12Th Ave, Miami 33136
Kendall Regional Medical Center
11750 Bird Rd, Miami 33175
Sylvester Comprehensive Cancer Center/UMHC
1475 West 12Th Ave, Miami 33136
University of Miami Hospital
1400 West 12Th Ave, Miami 33136
University Of Miami-Nephrology
1475 NW 12Th Ave, Miami 33136
Kendall Regional Medical Center
11750 Bird Rd, Miami 33175
Sylvester Comprehensive Cancer Center/UMHC
1475 West 12Th Ave, Miami 33136
University of Miami Hospital
1400 West 12Th Ave, Miami 33136
Education:
Medical Schools
Ruprecht Karls University Of Heidelberg
Graduated: 1998
Ruprecht Karls University Of Heidelberg
Graduated: 1998
Cathepsin L Mediated Diseases And Associated Methods And Products
Cathepsin L Mediated Diseases And Associated Methods And Products
US Patent:
2010027, Oct 28, 2010
Filed:
Jan 26, 2010
Appl. No.:
12/693523
Inventors:
Jochen Reiser - Miami FL, US
Sanja Sever - Brookline MA, US
Sanja Sever - Brookline MA, US
International Classification:
A61K 39/395, A61K 31/7088, A61K 38/02, A61K 38/46, A61K 38/16, A61P 3/10, A61P 9/12, A61P 9/00, C12N 5/00, C12Q 1/34, C12Q 1/68
US Classification:
4241301, 514 44 R, 514 11, 424 946, 514 212, 435375, 435 18, 435 6, 514 193
Abstract:
This invention relates generally to the treatment of cathepsin or dynamin mediated diseases, such as proteinuria, cancer, and cognitive disease and related products. Diagnostic and other assays are also provided, as well as methods for podocyte cell gene transfer.
Role Of Soluble Upar In The Pathogenesis Of Proteinuric Kidney Disease
Role Of Soluble Upar In The Pathogenesis Of Proteinuric Kidney Disease
US Patent:
2011021, Sep 1, 2011
Filed:
Nov 6, 2009
Appl. No.:
13/127848
Inventors:
Jochen Reiser - Miami FL, US
Assignee:
University of Miami Office of Technology Transfer - Miami FL
General Hospital Corporation d/b/a Massachusetts General Hospital - Boston MA
General Hospital Corporation d/b/a Massachusetts General Hospital - Boston MA
International Classification:
A61K 39/395, A61K 31/7105, A61K 38/02, A61K 31/7052, A61K 31/711, G01N 33/567, C07K 14/00, C07K 16/28, G01N 33/53, A61K 38/16, A61P 13/12
US Classification:
4241301, 514 44 R, 514 154, 514 52, 514 44 A, 435 721, 530350, 5303891, 436501
Abstract:
Compositions which specifically block urokinase receptor (uPAR) in podocytes; compositions which modulate or block soluble urokinase receptor (suPAR); compositions which modulate pathways in which uPAR is associated with, protect against renal diseases or disorders. Methods of treatment in vivo involve use of one or more compositions.
Limited Proteolysis Of Cd2Ap And Progression Of Renal Disease
Limited Proteolysis Of Cd2Ap And Progression Of Renal Disease
US Patent:
2011023, Sep 29, 2011
Filed:
Nov 6, 2009
Appl. No.:
13/127839
Inventors:
Jochen Reiser - Miami FL, US
Brian Adair - Malden MA, US
Brian Adair - Malden MA, US
Assignee:
University of Miami - Miami FL
Massachusetts General Hospital - Boston MA
Massachusetts General Hospital - Boston MA
International Classification:
A61K 39/395, A61K 38/48, A61K 31/7088, A61K 38/02, A61K 38/43, C12Q 1/37, C12Q 1/02, C07K 14/47, C12N 15/63, C07K 16/18, C12N 9/00, C12N 9/64, C12N 9/14, A61P 13/12, A61P 3/10, A61P 7/00, A61P 35/00, A61P 31/00
US Classification:
4241581, 424 9465, 514 44 R, 514 202, 514 44 A, 514 11, 424 941, 435 23, 435 29, 530350, 4353201, 5303898, 5303879, 435183, 435226, 435195
Abstract:
Compositions which specifically block cathepsin L function in podocytes, compositions which protect cytoskeletal adaptor protein (CD2AP) for degradation, compositions which modulate expression or function of cytoskeletal adaptor protein (CD2AP), protect against renal diseases or disorders. Methods of treatment in vivo involve use of one or more compositions.
Novel Role Of Alpha-Galactosidase Activity As A Biomarker In Kidney Disease
Novel Role Of Alpha-Galactosidase Activity As A Biomarker In Kidney Disease
US Patent:
2012019, Aug 2, 2012
Filed:
Aug 13, 2010
Appl. No.:
13/390272
Inventors:
Jochen Reiser - Miami FL, US
International Classification:
A61K 38/47, A61P 13/12, A61P 35/00, C12N 9/40, C12Q 1/34
US Classification:
424 9461, 435208, 435 18
Abstract:
Biomarkers for diagnosis and differentiation between stages of kidney diseases. Methods of treatments and identification of novel therapies are provided.
Podocyte Ph Modulation And Uses Thereof
Podocyte Ph Modulation And Uses Thereof
US Patent:
2012021, Aug 30, 2012
Filed:
Sep 22, 2010
Appl. No.:
13/497451
Inventors:
Jochen Reiser - Miami FL, US
Assignee:
University of Miami - Miami FL
International Classification:
A61K 39/395, C12Q 1/37, G01N 33/48, C12N 9/50, G01N 21/64, C07K 14/47, A61K 38/02, C07H 21/00, C07K 2/00, C07K 16/18, C07K 14/00, C12Q 1/02, A61K 31/7088
US Classification:
4241301, 435 29, 435 23, 436163, 435219, 514 44 R, 514 11, 536 231, 530300, 5303871, 530350
Abstract:
Compositions are directed to the treatment of kidney diseases in a cell-specific manner. Methods of treating kidney diseases comprise the use of the compositions. Assays for identification of further compounds are provided. Biomarkers for predisposition to kidney diseases and diagnosis are identified.
Methods And Compositions For The Treatment Of Proteinuric Diseases
Methods And Compositions For The Treatment Of Proteinuric Diseases
US Patent:
2010029, Nov 25, 2010
Filed:
Nov 7, 2008
Appl. No.:
12/740090
Inventors:
Jochen Reiser - Miami FL, US
International Classification:
A61K 39/395, A61K 38/02, A61K 38/06, A61P 13/12, A61P 37/06, A61P 7/00, A61P 31/04, A61P 31/12, A61P 29/00
US Classification:
4241431, 514 211, 514 219
Abstract:
The present invention is directed to methods of treating proteinuric diseases by the administration of avĪ²3 integrin inhibitors.
Podocyte Specific Assays And Uses Thereof
Podocyte Specific Assays And Uses Thereof
US Patent:
2012025, Oct 4, 2012
Filed:
Nov 8, 2010
Appl. No.:
13/508088
Inventors:
Jochen Reiser - Miami FL, US
Assignee:
University of Miami - Miami FL
International Classification:
G01N 21/76, C12N 15/63, G01N 33/82, C07K 16/18, A61P 3/10, A61P 13/12, A61P 31/00, A61P 35/00, C12Q 1/68, A61K 39/395
US Classification:
4241301, 435 61, 435 618, 4353201, 435 721, 435 613, 530350, 435 71
Abstract:
Compositions are directed to the treatment of kidney diseases in a cell-specific manner. Methods of treating kidney diseases comprise the use of the compositions. Assays for identification of further compounds are provided.
Treatment Of Renal Diseases
Treatment Of Renal Diseases
US Patent:
2012021, Aug 23, 2012
Filed:
Feb 22, 2012
Appl. No.:
13/402689
Inventors:
Jochen Reiser - Miami FL, US
International Classification:
A61K 39/395, A61P 13/12, C07K 16/28
US Classification:
4241331, 4241721, 4241431, 4241421, 5303891
Abstract:
Compositions for the treatment of renal diseases and disorders utilize agents which inhibit alphaV integrin molecules in vivo. Methods of treatment include use of these agents in the prevention and treatment of proteinuria, progressive glomerular disease and glomerular disease amongst others.